Women With Ankylosing Spondylitis Switch Drugs Sooner Than Men

June 14, 2018
Gregory M. Weiss, MD

Men are more likely to stay the course of TNF inhibitor therapy.

Reference1. Rusman T, Ten Wolde S, Euser SM, et al. Gender differences in retention rate of tumor necrosis factor alpha inhibitor treatment in ankylosing spondylitis: a retrospective cohort study in daily practice. Int J Rheum Dis. 2018;21:836-842. doi: 10.1111/1756-185X.13271.